Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings https://ir.acurxpharma.com/all-sec-filings/rss Acurx Pharmaceuticals, Inc. (ACXP) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_74d3ddac4a4cd7a02a49b753693fb2b6/acurxpharma/logo.png Acurx Pharmaceuticals, Inc. Logo https://ir.acurxpharma.com Equisolve Investor Relations Suite <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578 Tue, 12 May 26 06:07:09 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578 <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577 Tue, 12 May 26 06:07:01 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577 <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298 Tue, 12 May 26 15:05:23 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298 <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-526-0001104659-26-059296 Tue, 12 May 26 15:04:32 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-526-0001104659-26-059296 <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-519-0001104659-26-058631 Mon, 11 May 26 16:12:03 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-519-0001104659-26-058631 <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887 Mon, 04 May 26 16:13:05 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887 <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-511-0001104659-26-054884 Mon, 04 May 26 16:09:28 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-511-0001104659-26-054884 <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-510-0001736243-26-000001 Wed, 29 Apr 26 16:20:23 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-510-0001736243-26-000001 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-509-0001104659-26-046846 Wed, 22 Apr 26 16:21:45 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-509-0001104659-26-046846 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-508-0001104659-26-046844 Wed, 22 Apr 26 16:21:03 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-508-0001104659-26-046844